SCTL 1.1 (+0%)
US75629F1093Drug ManufacturersDrug Manufacturers - Specialty & Generic

Societal CDMO (SCTL) Competitor Comparison

We are evaluating the key criteria listed to compare Societal CDMO (SCTL) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Total Revenue - SCTL ranking 33 / 50

These are the competitors of Societal CDMO in the industry Drug Manufacturers - Specialty & Generic ranked by total revenue
1. Teva Pharmaceutical Industries TEVA
15.27B
2. Linc LNC
14.74B
3. Bausch Health Companies BHC
8.54B
4. Zoetis ZTS
8.37B
5. Perrigo PRGO
4.65B
6. Elanco Animal Health ELAN
4.37B
7. Catalent CTLT
4.22B
8. Amneal Pharmaceuticals AMRX
2.39B
9. Vifor Pharma G2AB.F
1.96B
10. Curaleaf Holdings CURLF
1.4B
11. Embecta EMBC
1.12B
12. Emergent BioSolutions EBS
1.1B
13. PetIQ PETQ
1.07B
14. Green Thumb Industries R9U2.F
1.04B
15. Phibro Animal Health PAHC
976.72M
16. Tilray Brands TLRY
700.5M
17. Pacira BioSciences PCRX
665.69M
18. Supernus Pharmaceuticals SUPN
610.53M
19. Amphastar Pharmaceuticals AMPH
601.31M
20. Taro Pharmaceutical Industries TARO
592.88M
21. Collegium Pharmaceutical COLL
546.64M
22. Ayr Wellness 3KJB.F
507.26M
23. Ascend Wellness Holdings AAWH
490.53M
24. ANI Pharmaceuticals ANIP
449.39M
25. Organogenesis Holdings ORGO
449M
26. Ironwood Pharmaceuticals IRWD
432.38M
27. Procaps Group PROC
414.1M
28. Eagle Pharmaceuticals EGRX
257.55M
29. Evolus EOLS
184.73M
30. Kamada KMDA
151.53M
31. SCYNEXIS SCYX
135.87M
32. Harrow Health HROW
114.17M
33. Societal CDMO SCTL
91.2M
34. Cronos Group CRON
90.51M
35. Journey Medical DERM
79.89M
36. Theratechnologies THTX
79.73M
37. Flora Growth FLGC
72.42M
38. OptiNose OPTN
71.98M
39. Alimera Sciences ALIM
68.48M
40. Alvotech ALVO
63.75M
41. ProPhase Labs PRPH
62.71M
42. Cumberland Pharmaceuticals CPIX
39.32M
43. Alpha Teknova TKNO
36.71M
44. Universe Pharmaceuticals UPC
34.41M
45. Biofrontera BFRI
33.62M
46. Clever Leaves Holdings CLVR
18.57M
47. Kolinpharma KIP.MI
16.75M
48. Avadel Pharmaceuticals AVDL
8.51M
49. Jupiter Wellness JUPW
6.6M
50. Solid Biosciences SLDB
0

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.